• Company
• More treatment options for rheumatoid arthritis available
• by Hwang, Byung-woo Sep 5, 2024 05:51am

• Company
• J&J appoints Christian Rodseth as new Managing Director
• by Hwang, Byung-woo Sep 5, 2024 05:51am

• Company
• New drug Voranigo receives orphan drug designation in Korea
• by Eo, Yun-Ho Sep 4, 2024 05:49am

• Company
• Yuhan's investment in US subsidiary total KRW 27B over 5 yrs
• by Chon, Seung-Hyun Sep 4, 2024 05:48am

• Company
• Generic companies lastly challenge Lixiana patent
• by Kim, Jin-Gu Sep 4, 2024 05:48am

• Company
• Pharma companies jump into developing 'TPD' for cancer
• by Son, Hyung-Min Sep 3, 2024 05:53am

• Company
• Biological drug options for psoriasis treatment increase
• by Son, Hyung-Min Sep 2, 2024 05:48am

• Company
• Yuhan’s Leclaza targets US mkt based on its clinical effect
• by Hwang, Byung-woo Sep 2, 2024 05:48am

• Company
• Tevimbra may be prescribed in general hospitals in KOR
• by Eo, Yun-Ho Sep 2, 2024 05:48am

• Company
• API competition↑ with entry of Chinese and Indian pharmas
• by Son, Hyung-Min Aug 30, 2024 05:50am